Misdiagnosed acute Q fever due to Coxiella burnetii in Guangxi China: A case report and literature review
Abstract
Coxiella burnetii (C. burnetii), a Gram-negative obligate intracellular bacterium, is the etiological agent of Q fever. Timely diagnosis and initiation of appropriate therapy are critical for favorable clinical outcomes, particularly in cases of acute Q fever. This report describes a case of C. burnetii infection in a 35-year-old male electrical grid engineer who presented with a 4-day history of febrile illness, peaking at 40.0 °C. Associated symptoms included night sweats, chills, anorexia, nausea, non-productive cough, and chest tightness. During hospitalization, the patient also developed headache and vomiting. Metagenomic next-generation sequencing (mNGS) of peripheral blood identified C. burnetii as the causative pathogen. The patient was treated with oral doxycycline (100 mg twice daily) for 14 days and levofloxacin (500 mg once daily) for 5 days. Following antimicrobial therapy, the patient's symptoms resolved rapidly, with no clinical evidence of relapse or progression to chronic Q fever during follow-up. This report describes a case of Q fever diagnosed by mNGS. The case highlights the diagnostic value of mNGS in patients presenting with febrile illness of unknown origin. It also serves as a reminder to clinicians that, even in regions where Q fever is enzootic in animals but no human cases have been reported, the possibility of human infection should not be overlooked.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.